Learn About Impotence, AIDS, penile implants, vasectomy, prostate cancer and other Sex-Related Health Issues
A Member of the Healthscout Network
 Printer Friendly  Send to a Friend

Testing of Brothers May Boost Family's Prostate Cancer Rates

Increased diagnostic activity may lead to siblings finding more early stage disease, study suggests

THURSDAY, Aug. 19 (HealthDay News) -- Men who have a brother with prostate cancer are more likely than other men to be diagnosed with the disease, but the reason may have more to do with greater surveillance than genetics, a new study suggests.

Swedish researchers analyzed data from 22,511 brothers of 13,975 prostate cancer patients and found that the incidence of the disease was higher among brothers of prostate cancer patients than men of the same age in the general population. Disease incidence was highest among men who had two brothers with prostate cancer.

Advertisement
Related Stories
 border=
Satisfaction With Life Seems Good for the Heart
New Combo Therapy May Prevent TB, Save Lives in People With HIV
Cuddling May Be Key to Long-Term Happy Relationship
Related Videos
 border=
Baby Steps: Fertility Findings
Don't Wait on Your Prostate
Risky Wrap: The Dangers of Swaddling
Related Slides
 border=
Penile Implants
Placenta Abruptio
PMS
Related Encyclopedia
 border=
AIDS and HIV Infection
Ankylosing Spondylitis
Baldness


However, the study found that early-stage disease was the type most often diagnosed in brothers of prostate cancer patients. This stage of prostate cancer is typically detected through a prostate specific antigen (PSA) test and may or may not be clinically relevant, the study authors explained in the report published online Aug. 19 in the Journal of the National Cancer Institute.

The researchers also found that the incidence of prostate cancer among brothers of prostate cancer patients was highest during the first year after the first brother's diagnosis.

"The increased diagnostic activity among men with a family history of prostate cancer, which we observed, will inflate family history as a risk factor for prostate cancer in populations of men who commonly receive PSA testing," concluded Dr. Ola Bratt, of the urology department at the Helsinborg Hospital in Sweden, and colleagues.

The study results could offer guidance to doctors, the authors suggested.

"When counseling men about their risk of hereditary predisposition to prostate cancer, one should consider the possibility that a familial aggregation of prostate cancer may be at least partially caused by increased diagnostic activity," Bratt and colleagues wrote.

More information

The American Cancer Society has more about prostate cancer.

-- Robert Preidt

SOURCE: Journal of the National Cancer Institute, news release, Aug. 19, 2010

Copyright © 2010 HealthDay. All rights reserved.
Last updated 8/19/2010



Disclaimer: The information provided on this website is for educational purposes only and does not serve as a replacement for care provided by your own personal health care team. This website does not render or provide medical advice, and no individual should make any medical decisions or change their health behavior based on information provided here. All pertinent content provided on this website should be discussed with your personal physician to evaluate whether it has any relevance to or impact on your specific condition. Reliance on any information provided by this website is solely at your own risk.


Feb 4, 2012
Home
Search
Powered By HealthLine
New! For timely and trustworth health information, expert advice and much more, visit Erectile Dysfunction Forum
Patient Guide
News
Health Videos
Health Encyclopedia
Health News Archive
Affiliate Information
HealthScout Network
Contact Us
Newsletters
Privacy Policy
Terms of Use

We comply with the HONcode standard for trustworthy health
information:
verify here.
About The HealthScout Network Contact Us
Copyright © 2001. The HealthCentralNetwork, Inc. All rights reserved.
Privacy Policy  Terms of Service  

To find more information on specific conditions, please visit our partner sites: